miércoles, 12 de febrero de 2020

Different doses of galcanezumab versus placebo in patients with migraine and cluster headache: a meta-analysis of randomized controlled trials | The Journal of Headache and Pain | Full Text

Different doses of galcanezumab versus placebo in patients with migraine and cluster headache: a meta-analysis of randomized controlled trials | The Journal of Headache and Pain | Full Text



Galcanezumab is a novel monoclonal antibody that target to calcitonin gene-related peptide (CGRP). It has been tested for the preventive treatment of migraine and episodic cluster headache by multiple randomiz...
Authors:Yanbo Yang, Zilan Wang, Bixi Gao, He Xuan, Yun Zhu, Zhouqing Chen and Zhong Wang
Citation:The Journal of Headache and Pain 2020 21:14
Content type:Research article
Published on: 

No hay comentarios:

Publicar un comentario